benzthiazide

Trade name: fovane

Small moleculeapproved

Approved

Jun 1, 1960

Benzthiazide (trade names Aquatag, Dihydrex, Diucen, Edemax, Exna, Foven and others) is a thiazide diuretic used in the treatment of high blood pressure and edema. It is no longer available in the United States. As a diuretic, benzthiazide inhibits active chloride reabsorption at the early distal tubule via the Na-Cl cotransporter, resulting in an increase in the excretion of sodium, chloride, and water. The following is a list of possible side effects that may occur from all constituting ingredients of Exna Tablet: vomiting, diarrhoea, photosensitivity reactions, increased in uric acid concentrations, megaloblastic anaemia, thrombocytopenia. Exna tablet may interact with the following drugs and products: ACE inhibitors, angiotensin II receptor antagonists, potassium-sparing diuretics. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 4 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1960s

  1. Jun 1, 1960

    Earliest FDA Approval

  2. Oct 14, 1960

    AH Robins — First NDA Organization

  3. Oct 14, 1960

    AH Robins — NDA Secondary Org

  4. Oct 14, 1960

    AH Robins — NDA Organization

  5. Aug 17, 1965

    Solvay — NDA Secondary Org

1970s

  1. Nov 19, 1976

    Mylan — Marketing Organization

Indications

Mechanism of action

Approval history

  • approvedJun 1, 1960

Chemistry & pharmacology

Loading structure…

SMILES

NS(=O)(=O)C1=C(Cl)C=C2N=C(CSCC3=CC=CC=C3)NS(=O)(=O)C2=C1
Mol. weight
431.937 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Oral
Availability
Discontinued

Oral

Yes

Parenteral

No

Topical

No

Sources

Also known as

  • 3-benzylthiomethyl-6-chloro-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
  • 3-benzylthiomethyl-6-chloro-2h-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
  • 3-benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide
  • 3-benzylthiomethyl-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide
  • 3-((benzylthio)methyl)-6-chloro-7-sulfamoyl-2h-benzo-1,2,4-thiadiazine 1,1-dioxide
  • 3-((benzylthio)methyl)-6-chloro-7-sulfamoyl-2h-benzo-1,2,4-thiadiazine 1,1-dioxide
  • 3-((benzylthio)methyl)-6-chloro-7-sulfamoyl-2h-benzo-1,2,4-thiadiazine-1,1-dioxide
  • 6-chloro-1,1-dioxo-3-(phenylmethylsulfanylmethyl)-4h-benzo[e][1,2,4]thiadiazine-7-sulfonamide
  • 6-chloro-1,1-dioxo-3-(phenylmethylsulfanylmethyl)-4h-benzo[e][1,2,4]thiadiazine-7-sulfonamide
  • 6-chloro-7-sulfamoyl-3-benzylthiomethyl-2h-1,2,4-benzothiadiazine 1,1-dioxide
  • 6-chloro-7-sulfamoyl-3-benzylthiomethyl-2h-1,2,4-benzothiadiazine 1,1-dioxide
  • aquatag
  • aquatag
  • benzothiazide
  • benzothiazide
  • benzothiazide
  • benzothiazide
  • benzotiazida
  • benzotiazida
  • benzthiazid
  • benzthiazid
  • benzthiazide
  • benzthiazide
  • benzthiazide
  • benzthiazide
  • benzthiazide
  • benzthiazide
  • benzthiazide
  • benzthiazide
  • benzthiazide
  • benzthiazide
  • benzthiazidum
  • benzthiazidum
  • benztiazide
  • benztiazide
  • dihydrex
  • exna
  • exna
  • fovane
  • fovane
  • fovane
  • lemazide
  • urese
  • urese

Organizations

Marketing (5)

OrganizationOrg typeRelationshipDate
AH RobinsFor profitNDA2Oct 14, 1960
AH RobinsFor profitNDAOct 14, 1960
MylanFor profitMKTGNov 19, 1976
PfizerFor profitNDA2
SolvayFor profitNDA2Aug 17, 1965